Cipla Ltd (CIPLA) Share Price Target Tomorrow| Prediction | Forecast for Intraday
The last closing price of CIPLA is 903 at 24-Apr-23 3:15:00 PM. We are providing CIPLA share price target on Intraday basis. These levels and targets calculated on the last 15mins candle. Current Support of CIPLA is 901.2 and Resistance is 905.7 on 15mins basis.
Live CIPLA share price target And Buy/Sell Levels
|Last Updated at||Last Price||Buy Above||Short Below|
|24-Apr-23 3:15:00 PM||903||905.7||901.2|
For Intraday purpose:
Buying can be above 905.7 And CIPLA share price target can be 911.13, 916.57, 923.81
Shorting can be below 901.2 And CIPLA share price target can be 895.79, 890.39, 883.18
This information is only for educational purpose, Please read carefully disclaimer of the website.
There is more information given below of the stock's detailed Technical analysis with the help of all indicators.
Technical Analysis of CIPLALast Updated at: 24-Apr-23 11:40:00 AM
Short Moving Average(21 Days)
CIPLA is Bullish on short moving average. Short moving average period is 21 Days.
Medium Moving Average(50 Days)
CIPLA is Bearish on Medium moving average. Medium moving average period is 50 Days.
Long Moving Average(100 Days)
CIPLA is Bearish on Long moving average. Medium moving average period is 100 Days.
CIPLA is Bullish on MACD indicator. MACD Stands for Moving Average Convergence Divergence.It is a trend following momentum indicator. For calculation three moving averages are taken which are 9 day EMA, 12 day EMA & 26 day EMA.
CIPLA is Bullish on Aroon indicator. The Aroon indicator is a technical indicator that is used to identify trend changes in the price of an asset, as well as the strength of that trend. In essence, the indicator measures the time between highs and the time between lows over a time period
CIPLA is Bearish on Stochastic indicator.
CIPLA is Neutral on Bolinger Band.
Sector: Health Technology
Industry: Pharmaceuticals: Other
Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.